These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 887795)

  • 1. Prostaglandins H1 and H2. Convenient biochemical synthesis and isolation. Further biological and spectroscopic characterization.
    Gorman RR; Sun FF; Miller OV; Johnson RA
    Prostaglandins; 1977 Jun; 13(6):1043-53. PubMed ID: 887795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activities of prostaglandin H1 analogs.
    Morita A; Nishino H; Mori M; Hasegawa K; Sakai K; Kobayashi S
    Prostaglandins; 1979 Oct; 18(4):529-40. PubMed ID: 531224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
    Hamberg M; Svensson J; Wakabayashi T; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):345-9. PubMed ID: 4521806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic preparation of prostaglandin endoperoxides.
    Ubatuba FB; Moncada S
    Prostaglandins; 1977 Jun; 13(6):1055-66. PubMed ID: 887796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and chemical conversion of two novel prostaglandin endoperoxides: 5(6)-epoxy-PGG1 and 5(6)-epoxy-PGH1.
    Oliw EH
    FEBS Lett; 1984 Jul; 172(2):279-83. PubMed ID: 6745418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Moncada S; Gryglewski R; Bunting S; Vane JR
    Nature; 1976 Oct; 263(5579):663-5. PubMed ID: 802670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin endoperoxides IV. Effects on smooth muscle.
    Hamberg M; Hedqvist P; Strandberg K; Svensson J; Samuelsson B
    Life Sci; 1975 Feb; 16(3):451-62. PubMed ID: 1128158
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparative HPLC purification of prostaglandin endoperoxides and isolation of novel cyclooxygenase-derived arachidonic acid metabolites.
    Hecker M; Hatzelmann A; Ullrich V
    Biochem Pharmacol; 1987 Mar; 36(6):851-5. PubMed ID: 3105538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activity of prostaglandins and prostaglandin antagonists.
    Fried J; Lin C; Mehra M; Kao W; Dalven P
    Ann N Y Acad Sci; 1971 Apr; 180():38-63. PubMed ID: 4999659
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and biological evaluation of omega-homologues of prostaglandin E1.
    Dajani EZ; Rozek LF; Sanner JH; Miyano M
    J Med Chem; 1976 Aug; 19(8):1007-10. PubMed ID: 966245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGD3 is the mediator of the antiaggregatory effects of the trienoic endoperoxide PGH3.
    Whitaker MO; Needleman P; Wyche A; Fitzpatrick FA; Sprecher H
    Adv Prostaglandin Thromboxane Res; 1980; 6():301-3. PubMed ID: 6966885
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
    Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
    J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of CYP4F21: a prostaglandin E2 20-hydroxylase of ram seminal vesicles.
    Bylund J; Oliw EH
    Arch Biochem Biophys; 2001 May; 389(1):123-9. PubMed ID: 11370662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of dl-4,5,6-trinor-3,7-inter-m-phenylene-3oxaprostaglandins including one which inhibits platelet aggregation.
    Nelson NA; Jackson RW; Au AT; Wynalda DJ; Nishizawa EE
    Prostaglandins; 1975 Nov; 10(5):795-806. PubMed ID: 1215542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E antagonist activity of 11-deoxy-16,16-trimethyleneprostaglandin E1.
    Birnbaum JE; Tolman EL
    Prostaglandins; 1979 Sep; 18(3):349-57. PubMed ID: 531217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fast, nondestructive purification scheme for prostaglandin H2 using a nonaqueous, bonded-phase high-performance liquid chromatography system.
    Zulak IM; Puttemans ML; Schilling AB; Hall ER; Venton DL
    Anal Biochem; 1986 Apr; 154(1):152-61. PubMed ID: 3085539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation.
    Bunting S; Gryglewski R; Moncada S; Vane JR
    Prostaglandins; 1976 Dec; 12(6):897-913. PubMed ID: 1005741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.